SIMON H. STERTZER, M.D. - Corporate Board Profile

BioCardia, Inc.

Filing Date	Source Excerpt
2017-04-28	Simon H. Stertzer, M.D. is Chairman of our board of directors... Member of the compensation committee and nominating and corporate governance committee... Compensation for 2016: $14,423.06.
2018-04-27	Simon H. Stertzer, M.D. is Chairman of our board of directors and has served on our board of directors since 2002. ... Member of the compensation committee ... Member of the nominating and corporate governance committee ... The following table sets forth summary information concerning the compensation awarded to, paid to, or earned by the non-employee members of our board of directors for the fiscal year ended December 31, 2017: ... Simon H. Stertzer, M.D. ... Total ($) 297,225.00
2019-10-15	Simon H. Stertzer, M.D. is Chairman of our board of directors and has served on our board of directors since 2002. Dr. Stertzer is a Professor of Medicine, Emeritus at the Stanford University School of Medicine, Division of Cardiovascular Medicine, and a Professor at the Stanford University Biodesign Program. He served as Assistant Resident in Medicine at New York University and later as Chief Medical Resident at New York University Division of Bellevue Hospital. Dr. Stertzer was a founder and board member of Arterial Vascular Engineering, an angioplasty balloon and stent company that went public in 1996 and was subsequently acquired by Medtronic. Dr. Stertzer served as Director of the Catheterization Laboratory at Lenox Hill Hospital from 1971 to 1983. He also served as Director of AVIA App LLC and Frontiere Algorithmic Design LLC, each since 2015. He was the Director of Medical Research and Director of the Cardiac Catheterization Laboratory at the San Francisco Heart Institute from 1983 until 1993. He was appointed Professor of Medicine at Stanford University in 1998, and became Professor Emeritus at Stanford University in 2011. Dr. Stertzer received his Doctor of Medicine degree from New York University. He also earned a Certificat de Physiologie from University of Paris (Sorbonne) and had a fellowship at New York University Hospital in Cardiovascular Disease. Dr. Stertzer received a Bachelor of Arts degree in Humanities from Union College.
2020-12-02	Simon H. Stertzer, M.D. has served on our board of directors since 2002. He is the chair of the nominating and corporate governance committee. In 2019, Simon H. Stertzer, M.D. earned $76,250 in fees as a non-employee director.
2021-04-30	Simon H. Stertzer, M.D. has served on our board of directors since 2002. ... (4) Member of the science and technology committee ... The following table sets forth summary information concerning the compensation awarded to, paid to, or earned by the non-employee members of our board of directors for the fiscal year ended December 31, 2020: ... Simon H. Stertzer, M.D. $ 231,773 ...
2022-04-27	Simon H. Stertzer, M.D.(4) 86 Director 2002 2022 2025; Member of the science and technology committee; The following table sets forth summary information concerning the compensation awarded to, paid to, or earned by the non-employee members of our board of directors for the fiscal year ended December 31, 2021: Simon H. Stertzer, M.D. $33,750 Fees Earned or Paid in Cash, $9,999 Stock Awards, $47,559 Option Awards, Total $91,308.
2023-09-01	Simon H. Stertzer, M.D. has served on our board of directors since 2002. Dr. Stertzer is a Professor of Medicine, Emeritus at the Stanford University School of Medicine, Division of Cardiovascular Medicine. He was appointed Professor of Medicine at Stanford University in 1998, and became Professor Emeritus at Stanford University in 2011. Dr. Stertzer serves on the medical advisory board of Avenda Health, a private prostate cancer therapy company, and was appointed in June 2019. Dr. Stertzer is managing member of Windrock Enterprises, LLC, a real estate investment company since May 1999. He has served as a Director of Frontiere Algorithmic Design LLC, and AIVA App LLC, both software development companies, from June 2014 to October 2020. Dr. Stertzer was a founder and board member of Arterial Vascular Engineering, an angioplasty balloon and stent company that went public in 1996 and was subsequently acquired by Medtronic. He also serves as Director of AVIA App LLC since 2015. Dr. Stertzer received his Doctor of Medicine degree from New York University. He also earned a Certificat de Physiologie from University of Paris (Sorbonne) and had a fellowship at New York University Hospital in Cardiovascular Disease. Dr. Stertzer received a Bachelor of Arts degree in Humanities from Union College.
2024-04-15	Simon H. Stertzer, M.D. has served on our board of directors since 2002. ... (3) Member of the audit committee ... The following table sets forth summary information concerning the compensation awarded to, paid to, or earned by the non-employee members of our board of directors for the fiscal year ended December 31, 2023: ... Simon H. Stertzer, M.D. Fees Earned or Paid in Cash($) 43,261, Total ($) 47,549.